JezK

Edit File: 1585815683.M516294P2288701.mocha3025.mochahost.com,S=47699,W=48466:2,S

Envelope-to: nooromari@jack.ngo,
 ahmad@jack.ngo,
 takal@jack.ngo,
 hadi@jack.ngo,
 hafiz@jack.ngo,
 ghani@jack.ngo,
 musawy@jack.ngo,
 haroon.mahmoodi@jack.ngo
Delivery-date: Thu, 02 Apr 2020 04:21:23 -0400
MIME-Version: 1.0
References: <AM6PR01MB579909702CA5C40DA60689C0FAC60@AM6PR01MB5799.eurprd01.prod.exchangelabs.com>
In-Reply-To: <AM6PR01MB579909702CA5C40DA60689C0FAC60@AM6PR01MB5799.eurprd01.prod.exchangelabs.com>
From: "Dr.Nasir Ahmad tokhi" <nasir.tokhi123@gmail.com>
Date: Thu, 2 Apr 2020 12:48:07 +0430
Message-ID: <CAJX2XaJ3gn=ZXjdketj=tkbRxyhKE2q4p=tt1ctj+OXQosVVEA@mail.gmail.com>
Subject: Fwd: Stock status of Anti-Malarial Medicine at SRs level in each province
To: Khairullah Naderi <khairullahnaderi@gmail.com>
Cc: Nooromari <nooromari@jack.ngo>, =?UTF-8?Q?=E2=80=8BNoor_Ahmad?= <ahmad@jack.ngo>, 
	Sardar Wali Takal <takal@jack.ngo>, hadi@jack.ngo, hafiz@jack.ngo, 
	Said Daud Ghani <ghani@jack.ngo>, musawy@jack.ngo, haroon.mahmoodi@jack.ngo, 
	Majeed Hasan <majeedhasan1984@gmail.com>
Content-Type: multipart/mixed; boundary="0000000000007fbdce05a24a7181"

--0000000000007fbdce05a24a7181
Content-Type: multipart/related; boundary="0000000000007fbdcd05a24a7180"

--0000000000007fbdcd05a24a7180
Content-Type: multipart/alternative; boundary="0000000000007fbdcc05a24a717f"

--0000000000007fbdcc05a24a717f
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

Dear Dr Khairullah Naderi,
Greeting from Kabul,
Please kindly find attached file and fill the required information base on
below email direction with close coordination of provincial pharmacy
department and send back to me. if you have any question please let me know=
.

Best Regard,

*Dr. Nasir Ahmad =E2=80=9CTokhi=E2=80=9D *MD, MPH

*Malaria Project Manager / P4P and Reporting Focal Point*

*Just for Afghan Capacity and Knowledge**       =D8=A8=D9=84=D9=86=D8=AF =
=D8=A8=D8=B1=D8=AF=D9=86 =D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =D8=A7=D9=81=D8=BA=D8=A7=
=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)  *

*Address**:* First Street of Karta-e-Chahar

Behind AWCC Main Office, House # 08

*Ph*: +93 705546907 , 799612015

*Email*: dr.tokhi@jack.ngo

*Website*:*www.jack.ngo *

---------- Forwarded message ---------
From: Shakirullah Sediqi <shakirullah.sediqi@undp.org>
Date: Thu, Apr 2, 2020 at 9:48 AM
Subject: Stock status of Anti-Malarial Medicine at SRs level in each
province
To: ohpm.mal.pm@gmail.com <ohpm.mal.pm@gmail.com>, ayob@aada.org.af <
ayob@aada.org.af>, cdc.kabul@bdn.org.af <cdc.kabul@bdn.org.af>, Dr
Hashmatullha Naimi <malariamanager.caf@gmail.com>, shdp.mpm@gmail.com <
shdp.mpm@gmail.com>, aziz.ur@brac.net <aziz.ur@brac.net>,
sqariburahman@yahoo.com <sqariburahman@yahoo.com>, najibrashed@gmail.com <
najibrashed@gmail.com>, malaria.pm@sanayee.org.af <malaria.pm@sanayee.org.a=
f>,
Dr.Mahmoud Zia <malaria_coordinator@saf.org.af>, Ghulam Najib Sakhizada <
ad.fin_director@saf.org.af>, Dr. Naqibullah Bashari <
program_director@saf.org.af>, nasir.tokhi123@gmail.com <
nasir.tokhi123@gmail.com>, dr.tajzad@baran.org.af <dr.tajzad@baran.org.af>,
hamayoon.fatimy@akdn.org <hamayoon.fatimy@akdn.org>,
naeem.mujaddidi@akdn.org <naeem.mujaddidi@akdn.org>, mpmanager@cha-net.org =
<
mpmanager@cha-net.org>, anwar.hassanzai@sca.org.af <
anwar.hassanzai@sca.org.af>, malariapm.kabul@mrca-asso.org <
malariapm.kabul@mrca-asso.org>, Dr.Mohammad Saeed <saeed@hewad.org.af>, Dr
Zia-U-Rahman Hanif <ziaurrahmanhanif@gmail.com>,
mirwaismansoor.hntpo@gmail.com <mirwaismansoor.hntpo@gmail.com>
Cc: Nahzat M Sami <nahzat.nazari30@gmail.com>, M.Naeem Habib <
drnaeem.09@gmail.com>, Hameeda Hameed <hamida_880@hotmail.com>, Naeemullah
Safi <safina@who.int>, Ahmadwalid sediqi <ahmadwalid.sediqi@undp.org>,
Sayeddaoud Mahmoodi <sayeddaoud.mahmoodi@undp.org>, Mohammadismail
Hassanzai <mohammadismail.hassanzai@undp.org>, Alim Atarud <
abdulalim.atarud@undp.org>, Iolanda Fortes <iolanda.fortes@undp.org>

Dear Respected SRs,

Kindly requesting you to send the stock status of anti-Malarial Medicine[
1. Tab. Chloroquine,2. ACT (Tab Artemether  + Lumefantrine) and 3.
Tab.Artesunate & Sulfadoxine + Pyrimethamine]  in attached format that
*procured
by the BPHS implementer* by COB 8,Apr,2020 to ensure NMLCP/MoPH &UNDP
regarding the stock status of anti-Malarial medicine at provincial level in
2020.

If you have any concern please let us know.

*                               Best Regards,*

*Dr. Shakirullah Sediqi, MD*

*Malaria Project Associate*

*UNDP/ Global Fund Program Afghanistan *

*UNOCA Compound, Jalalabad Road, *

*Kabul, Afghanistan*

*Mobile: +93 (0) 700613003 or +93 (0) 785434856 *

*Skype:  *

www.af.undp.org
<https://emea01.safelinks.protection.outlook.com/?url=3Dhttp%3A%2F%2Fwww.af=
.undp.org%2F&data=3D02%7C01%7Cshakirullah.sediqi%40undp.org%7C8501d51d064c4=
e1b41ad08d66962c516%7Cb3e5db5e2944483799f57488ace54319%7C0%7C0%7C6368122702=
65567882&sdata=3DO0wBoTYvNvnmcqm%2B6r9dre5a73q7HWRh%2B01KzIHNrZs%3D&reserve=
d=3D0>
Follow us:
<https://emea01.safelinks.protection.outlook.com/?url=3Dhttp://www.facebook=
.com/UNDP&data=3D02%7C01%7Cshakirullah.sediqi@undp.org%7C8501d51d064c4e1b41=
ad08d66962c516%7Cb3e5db5e2944483799f57488ace54319%7C0%7C0%7C636812270265577=
887&sdata=3D/NY2xRutT0ShjQb3U28d6llgoG//hNHjx9sGpVIRD74%3D&reserved=3D0>

<https://emea01.safelinks.protection.outlook.com/?url=3Dhttp://www.twitter.=
com/undp&data=3D02%7C01%7Cshakirullah.sediqi@undp.org%7C8501d51d064c4e1b41a=
d08d66962c516%7Cb3e5db5e2944483799f57488ace54319%7C0%7C0%7C6368122702655778=
87&sdata=3DCmpOBLNv16IodK4kyBWpgz8I1usa7lxFcdc9no9dwOM%3D&reserved=3D0>

--0000000000007fbdcc05a24a717f
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr"><div class=3D"gmail_default" style=3D"font-family:georgia,=
serif;color:#45818e">Dear Dr Khairullah Naderi,</div><div class=3D"gmail_de=
fault" style=3D"font-family:georgia,serif;color:#45818e">Greeting from Kabu=
l,</div><div class=3D"gmail_default" style=3D"font-family:georgia,serif;col=
or:#45818e">Please kindly find attached file and fill the required=C2=A0inf=
ormation base on below email direction with close coordination of provincia=
l pharmacy department and send back to me. if you have any question please =
let=C2=A0me know.</div><div><div dir=3D"ltr" class=3D"gmail_signature" data=
-smartmail=3D"gmail_signature"><div dir=3D"ltr"><div><div dir=3D"ltr"><div =
dir=3D"ltr"><div dir=3D"ltr"><div dir=3D"ltr"><a nam=
e=3D"SignatureSanitizer__MailAutoSig">Best Regard,</a> </p=
>

=
=C2=A0Dr. Nasir Ahmad =E2=80=9CTokhi=E2=80=9D <=
/b>MD, MPH

Malaria Project Manager / P4P and Reporting Focal Point</sp=
an>=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0

Just for Afghan Capacity and Knowledge<=
/span>=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0 =C2=A0=D8=A8=D9=84=D9=86=D8=AF =D8=A8=
=D8=B1=D8=AF=D9=86 =D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =D8=A7=D9=81=D8=BA=D8=A7=
=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)=C2=A0

Behind AWCC Main Office, House # 08

Email: <=
/span><a href=3D"mailto:dr.tokhi@jack.ngo" target=3D"_blank">dr.tokhi@jack.ngo</a=
>=C2=A0

Website:<u=
>www.jack.ngo=C2=A0</div></div></div></div></di=
v></div></div></div> <div class=3D"gmail_quote"><div dir=3D"ltr" cla=
ss=3D"gmail_attr">---------- Forwarded message --------- From: Shakirullah Sediqi &lt;<a href=3D"mailto:shakirullah.sediqi@undp.org">shakirullah.s=
ediqi@undp.org</a>&gt; Date: Thu, Apr 2, 2020 at 9:48 AM Subje=
ct: Stock status of Anti-Malarial Medicine at SRs level in each province<b=
r>To: <a href=3D"mailto:ohpm.mal.pm@gmail.com">ohpm.mal.pm@gmail.com</a> &l=
t;<a href=3D"mailto:ohpm.mal.pm@gmail.com">ohpm.mal.pm@gmail.com</a>&gt;, <=
a href=3D"mailto:ayob@aada.org.af">ayob@aada.org.af</a> &lt;<a href=3D"mail=
to:ayob@aada.org.af">ayob@aada.org.af</a>&gt;, <a href=3D"mailto:cdc.kabul@=
bdn.org.af">cdc.kabul@bdn.org.af</a> &lt;<a href=3D"mailto:cdc.kabul@bdn.or=
g.af">cdc.kabul@bdn.org.af</a>&gt;, Dr Hashmatullha Naimi &lt;<a href=3D"ma=
ilto:malariamanager.caf@gmail.com">malariamanager.caf@gmail.com</a>&gt;, <a=
 href=3D"mailto:shdp.mpm@gmail.com">shdp.mpm@gmail.com</a> &lt;<a href=3D"m=
ailto:shdp.mpm@gmail.com">shdp.mpm@gmail.com</a>&gt;, <a href=3D"mailto:azi=
z.ur@brac.net">aziz.ur@brac.net</a> &lt;<a href=3D"mailto:aziz.ur@brac.net"=
>aziz.ur@brac.net</a>&gt;, <a href=3D"mailto:sqariburahman@yahoo.com">sqari=
burahman@yahoo.com</a> &lt;<a href=3D"mailto:sqariburahman@yahoo.com">sqari=
burahman@yahoo.com</a>&gt;, <a href=3D"mailto:najibrashed@gmail.com">najibr=
ashed@gmail.com</a> &lt;<a href=3D"mailto:najibrashed@gmail.com">najibrashe=
d@gmail.com</a>&gt;, <a href=3D"mailto:malaria.pm@sanayee.org.af">malaria.p=
m@sanayee.org.af</a> &lt;<a href=3D"mailto:malaria.pm@sanayee.org.af">malar=
ia.pm@sanayee.org.af</a>&gt;, Dr.Mahmoud Zia &lt;<a href=3D"mailto:malaria_=
coordinator@saf.org.af">malaria_coordinator@saf.org.af</a>&gt;, Ghulam Naji=
b Sakhizada &lt;<a href=3D"mailto:ad.fin_director@saf.org.af">ad.fin_direct=
or@saf.org.af</a>&gt;, Dr. Naqibullah Bashari &lt;<a href=3D"mailto:program=
_director@saf.org.af">program_director@saf.org.af</a>&gt;, <a href=3D"mailt=
o:nasir.tokhi123@gmail.com">nasir.tokhi123@gmail.com</a> &lt;<a href=3D"mai=
lto:nasir.tokhi123@gmail.com">nasir.tokhi123@gmail.com</a>&gt;, <a href=3D"=
mailto:dr.tajzad@baran.org.af">dr.tajzad@baran.org.af</a> &lt;<a href=3D"ma=
ilto:dr.tajzad@baran.org.af">dr.tajzad@baran.org.af</a>&gt;, <a href=3D"mai=
lto:hamayoon.fatimy@akdn.org">hamayoon.fatimy@akdn.org</a> &lt;<a href=3D"m=
ailto:hamayoon.fatimy@akdn.org">hamayoon.fatimy@akdn.org</a>&gt;, <a href=
=3D"mailto:naeem.mujaddidi@akdn.org">naeem.mujaddidi@akdn.org</a> &lt;<a hr=
ef=3D"mailto:naeem.mujaddidi@akdn.org">naeem.mujaddidi@akdn.org</a>&gt;, <a=
 href=3D"mailto:mpmanager@cha-net.org">mpmanager@cha-net.org</a> &lt;<a hre=
f=3D"mailto:mpmanager@cha-net.org">mpmanager@cha-net.org</a>&gt;, <a href=
=3D"mailto:anwar.hassanzai@sca.org.af">anwar.hassanzai@sca.org.af</a> &lt;<=
a href=3D"mailto:anwar.hassanzai@sca.org.af">anwar.hassanzai@sca.org.af</a>=
&gt;, <a href=3D"mailto:malariapm.kabul@mrca-asso.org">malariapm.kabul@mrca=
-asso.org</a> &lt;<a href=3D"mailto:malariapm.kabul@mrca-asso.org">malariap=
m.kabul@mrca-asso.org</a>&gt;, Dr.Mohammad Saeed &lt;<a href=3D"mailto:saee=
d@hewad.org.af">saeed@hewad.org.af</a>&gt;, Dr Zia-U-Rahman Hanif &lt;<a hr=
ef=3D"mailto:ziaurrahmanhanif@gmail.com">ziaurrahmanhanif@gmail.com</a>&gt;=
, <a href=3D"mailto:mirwaismansoor.hntpo@gmail.com">mirwaismansoor.hntpo@gm=
ail.com</a> &lt;<a href=3D"mailto:mirwaismansoor.hntpo@gmail.com">mirwaisma=
nsoor.hntpo@gmail.com</a>&gt; Cc: Nahzat M Sami &lt;<a href=3D"mailto:na=
hzat.nazari30@gmail.com">nahzat.nazari30@gmail.com</a>&gt;, M.Naeem Habib &=
lt;<a href=3D"mailto:drnaeem.09@gmail.com">drnaeem.09@gmail.com</a>&gt;, Ha=
meeda Hameed &lt;<a href=3D"mailto:hamida_880@hotmail.com">hamida_880@hotma=
il.com</a>&gt;, Naeemullah Safi &lt;<a href=3D"mailto:safina@who.int">safin=
a@who.int</a>&gt;, Ahmadwalid sediqi &lt;<a href=3D"mailto:ahmadwalid.sediq=
i@undp.org">ahmadwalid.sediqi@undp.org</a>&gt;, Sayeddaoud Mahmoodi &lt;<a =
href=3D"mailto:sayeddaoud.mahmoodi@undp.org">sayeddaoud.mahmoodi@undp.org</=
a>&gt;, Mohammadismail Hassanzai &lt;<a href=3D"mailto:mohammadismail.hassa=
nzai@undp.org">mohammadismail.hassanzai@undp.org</a>&gt;, Alim Atarud &lt;<=
a href=3D"mailto:abdulalim.atarud@undp.org">abdulalim.atarud@undp.org</a>&g=
t;, Iolanda Fortes &lt;<a href=3D"mailto:iolanda.fortes@undp.org">iolanda.f=
ortes@undp.org</a>&gt; </div>

<div lang=3D"EN-US" link=3D"#0563C1" vlink=3D"#954F72">
<div class=3D"m_-8228084280900176220WordSection1">
Dear Respected SRs,
Kindly requesting you to send the stock status of an=
ti-Malarial Medicine[ 1. Tab. Chloroquine,2. ACT (Tab Artemether=C2=A0 + Lu=
mefantrine) and 3. Tab.Artesunate &amp; Sulfadoxine + Pyrimethamine] =C2=A0=
in attached format that
procured by the BPHS implementer by COB 8,Apr,2020 to ensure NMLCP/M=
oPH &amp;UNDP regarding the stock status of anti-Malarial medicine at provi=
ncial level in 2020.
If you have any concern please let us know.<u=
>
=C2=A0
=C2=A0=C2=A0=C2=
=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=
=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=
=A0=C2=A0=C2=A0 Best Regards,
=C2=A0<=
/u>
<table border=3D"0" cellspacing=3D"1" cellpadding=3D"0" align=3D"left" widt=
h=3D"386" style=3D"width:289.7pt;margin-left:6.75pt;margin-right:6.75pt">
<tbody>
<tr style=3D"height:14.05pt">
<td width=3D"81" valign=3D"top" style=3D"width:60.9pt;padding:1.5pt 1.5pt 1=
5.0pt 1.5pt;height:14.05pt">

<img width=3D"79" height=3D"148" style=3D"width:=
.8229in;height:1.5416in" id=3D"m_-8228084280900176220Picture_x0020_1" src=
=3D"cid:17139f01ccc4ce8e91">=

</td>
<td width=3D"302" valign=3D"top" style=3D"width:226.7pt;padding:1.5pt 1.5pt=
 1.5pt 1.5pt;height:14.05pt">

Dr. Shakirullah Sediqi,=
 MD</=
span>

Malaria Project Associa=
te</s=
pan>

UNDP/ Global Fund Program Afghanistan


UNOCA Compound, Jalalabad Road,


Kabul, Afghanistan

Mobile: +93 (0) 700613003 or +93 (0) 7=
85434856


Skype:=C2=A0


<a href=3D"https://emea01.safelinks.protection.=
outlook.com/?url=3Dhttp%3A%2F%2Fwww.af.undp.org%2F&amp;data=3D02%7C01%7Csha=
kirullah.sediqi%40undp.org%7C8501d51d064c4e1b41ad08d66962c516%7Cb3e5db5e294=
4483799f57488ace54319%7C0%7C0%7C636812270265567882&amp;sdata=3DO0wBoTYvNvnm=
cqm%2B6r9dre5a73q7HWRh%2B01KzIHNrZs%3D&amp;reserved=3D0" target=3D"_blank">=
www.af.undp.org</a>=C2=A0=C2=A0
 Follow us: <a href=3D"https://emea01.sa=
felinks.protection.outlook.com/?url=3Dhttp://www.facebook.com/UNDP&amp;data=
=3D02%7C01%7Cshakirullah.sediqi@undp.org%7C8501d51d064c4e1b41ad08d66962c516=
%7Cb3e5db5e2944483799f57488ace54319%7C0%7C0%7C636812270265577887&amp;sdata=
=3D/NY2xRutT0ShjQb3U28d6llgoG//hNHjx9sGpVIRD74%3D&amp;reserved=3D0" target=
=3D"_blank"><img border=
=3D"0" width=3D"17" height=3D"17" style=3D"width:.177in;height:.177in" id=
=3D"m_-8228084280900176220Picture_x0020_2" src=3D"cid:17139f01ccd5b16b22"><=
/span></a>=C2=A0=C2=A0<a href=3D"https://emea01.safelinks.protection.outlook.co=
m/?url=3Dhttp://www.twitter.com/undp&amp;data=3D02%7C01%7Cshakirullah.sediq=
i@undp.org%7C8501d51d064c4e1b41ad08d66962c516%7Cb3e5db5e2944483799f57488ace=
54319%7C0%7C0%7C636812270265577887&amp;sdata=3DCmpOBLNv16IodK4kyBWpgz8I1usa=
7lxFcdc9no9dwOM%3D&amp;reserved=3D0" target=3D"_blank"><img border=3D"0" width=3D"19" height=3D"17"=
 style=3D"width:.1979in;height:.177in" id=3D"m_-8228084280900176220Picture_=
x0020_3" src=3D"cid:17139f01ccd692e333"></a>=C2=A0=C2=A0<img widt=
h=3D"17" height=3D"17" style=3D"width:.177in;height:.177in" src=3D"cid:1713=
9f01ccd7745b44"><=
/span>
</td>
</tr>
</tbody>
</table>
 

=C2=A0
</div>
</div>

</div></div>

--0000000000007fbdcc05a24a717f--
--0000000000007fbdcd05a24a7180
Content-Type: image/jpeg; name="image001.jpg"
Content-Disposition: inline; filename="image001.jpg"
Content-Transfer-Encoding: base64
Content-ID: <17139f01ccc4ce8e91>
X-Attachment-Id: 17139f01ccc4ce8e91
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--0000000000007fbdcd05a24a7180
Content-Type: image/png; name="image002.png"
Content-Disposition: inline; filename="image002.png"
Content-Transfer-Encoding: base64
Content-ID: <17139f01ccd5b16b22>
X-Attachment-Id: 17139f01ccd5b16b22

iVBORw0KGgoAAAANSUhEUgAAABEAAAARCAIAAAC0D9CtAAAAAXNSR0IArs4c6QAAAAlwSFlzAAAO
xAAADsQBlSsOGwAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAAAJESURBVDhP
dVM9axRBGN6Z3b3kOOKBQUGSRlAMhqCVoIKNH1hY+A/Ewkb8CRZia62IlSA22gXsoqQ4FRHklCAc
JmqMBk/vK3u7t7sz7zvjM7veEQSHZ4adZ96P531nR7z93Gtu7XgY1rr1f0MIa60apScO7xP3X2w8
fP1NWLhMfIqvYieEW9yUwhgTd/rXLx6VvjS+p6XQfoFAajYqztIoTYbZiFiBAS89HQiqVmUYCmmY
KM8nGI2yemBPHaxfPnbg0tL+uZpMkwynDBtFhtkaExgylOlChzXWSzVdWJi9ce7IbC3Y7kR347j1
I69WfF9CvtBKM7OEH7yRDWuWK8r1fH16z5T/tPHp9pN3Hzb7IYpniGFDCI88VnrGWBCAJo95piJr
U0GU05svg5VW7+dOLkxp7WzgDHuXh0kb0nGS7a0G184unFmcr1QqV88v3blycnFuJklS0poLODnW
SOjTqC9zVao06Xa7cZJAwXDQ77TbcTQkVTRgDJSAvjkfILTU7gwfPGuuvt8E8fj52q1HLz9+7YQI
7oJmDCgFeYU25IU8FESktGXjblEbL2cBFYiJ0wKEDcqXFk5lidqtviBcOAgECz127Sl4Z8DoAbke
YJYUjktP/FmhL9DDiXVp8NfMFNos5ZYUE7QqSzqKhu3fvTQdWUY/wewCUqFv7ka1KiFYS6bl1ebN
e8vN1ta077lY41M0wMkZa8OtOXio0Jj174PG2vavfuI0FPwYkKfBiUZz/VVzY/erKR9C8Qr+HRB2
+vihP9N8Y9IL0Fp7AAAAAElFTkSuQmCC
--0000000000007fbdcd05a24a7180
Content-Type: image/png; name="image003.png"
Content-Disposition: inline; filename="image003.png"
Content-Transfer-Encoding: base64
Content-ID: <17139f01ccd692e333>
X-Attachment-Id: 17139f01ccd692e333
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--0000000000007fbdcd05a24a7180
Content-Type: image/png; name="image004.png"
Content-Disposition: inline; filename="image004.png"
Content-Transfer-Encoding: base64
Content-ID: <17139f01ccd7745b44>
X-Attachment-Id: 17139f01ccd7745b44

iVBORw0KGgoAAAANSUhEUgAAABEAAAARCAMAAAAMs7fIAAAAAXNSR0ICQMB9xQAAAANQTFRFAAAA
p3o92gAAAAF0Uk5TAEDm2GYAAAAJcEhZcwAADsQAAA7EAZUrDhsAAAAZdEVYdFNvZnR3YXJlAE1p
Y3Jvc29mdCBPZmZpY2V/7TVxAAAADUlEQVQoz2NgGAWkAQABMgABXn/JkgAAAABJRU5ErkJggg==
--0000000000007fbdcd05a24a7180--
--0000000000007fbdce05a24a7181
Content-Type: application/vnd.openxmlformats-officedocument.spreadsheetml.sheet; 
	name="Stock status of the Anti-Malaria Medicne at SRs level.xlsx"
Content-Disposition: attachment; 
	filename="Stock status of the Anti-Malaria Medicne at SRs level.xlsx"
Content-Transfer-Encoding: base64
Content-ID: <17139f01cceaad0f7635>
X-Attachment-Id: 17139f01cceaad0f7635
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--0000000000007fbdce05a24a7181--